Immunostimulation before chemotherapy in cancer treatment

L. Frati, A. Barzi, M. C. Caprino, E. Menconi, E. Bonmassar

Research output: Contribution to journalArticle

Abstract

Synergism between chemotherapy and immune responses has been evidenced in animals and man. In addition, non-specific immunostimulation seems to increase the efficiency of anticancer chemotherapy. Up to now most of the clinical trials have been conducted applying immunoadjuvants after initial chemotherapeutic treatment. Since presensitized immunocompetent cells are more radio- and chemo-resistant than non-stimulated lymphocytes, a trial of immunostimulation before chemotherapy is based on rational experimental basis. Such program, activated in humans during 1976, is conducted according to the following general scheme:o1.Chemotherapy alone2.Chemotherapy followed by BCG and recycle3.Chemotherapy preceded and followed by BCG and recycle. Protocols for breast, lung, colorectal and ovarian cancer treatment are described.

Original languageEnglish
Pages (from-to)689-699
Number of pages11
JournalPharmacological Research Communications
Volume9
Issue number8
DOIs
Publication statusPublished - 1977

Fingerprint

Immunization
Drug Therapy
Neoplasms
Mycobacterium bovis
Therapeutics
Immunologic Adjuvants
Radio
Ovarian Neoplasms
Colorectal Neoplasms
Lung Neoplasms
Clinical Trials
Lymphocytes
Breast Neoplasms

ASJC Scopus subject areas

  • Pharmacology

Cite this

Frati, L., Barzi, A., Caprino, M. C., Menconi, E., & Bonmassar, E. (1977). Immunostimulation before chemotherapy in cancer treatment. Pharmacological Research Communications, 9(8), 689-699. https://doi.org/10.1016/S0031-6989(77)80060-X

Immunostimulation before chemotherapy in cancer treatment. / Frati, L.; Barzi, A.; Caprino, M. C.; Menconi, E.; Bonmassar, E.

In: Pharmacological Research Communications, Vol. 9, No. 8, 1977, p. 689-699.

Research output: Contribution to journalArticle

Frati, L, Barzi, A, Caprino, MC, Menconi, E & Bonmassar, E 1977, 'Immunostimulation before chemotherapy in cancer treatment', Pharmacological Research Communications, vol. 9, no. 8, pp. 689-699. https://doi.org/10.1016/S0031-6989(77)80060-X
Frati, L. ; Barzi, A. ; Caprino, M. C. ; Menconi, E. ; Bonmassar, E. / Immunostimulation before chemotherapy in cancer treatment. In: Pharmacological Research Communications. 1977 ; Vol. 9, No. 8. pp. 689-699.
@article{6523cc1686424291b65d60cee182d9dd,
title = "Immunostimulation before chemotherapy in cancer treatment",
abstract = "Synergism between chemotherapy and immune responses has been evidenced in animals and man. In addition, non-specific immunostimulation seems to increase the efficiency of anticancer chemotherapy. Up to now most of the clinical trials have been conducted applying immunoadjuvants after initial chemotherapeutic treatment. Since presensitized immunocompetent cells are more radio- and chemo-resistant than non-stimulated lymphocytes, a trial of immunostimulation before chemotherapy is based on rational experimental basis. Such program, activated in humans during 1976, is conducted according to the following general scheme:o1.Chemotherapy alone2.Chemotherapy followed by BCG and recycle3.Chemotherapy preceded and followed by BCG and recycle. Protocols for breast, lung, colorectal and ovarian cancer treatment are described.",
author = "L. Frati and A. Barzi and Caprino, {M. C.} and E. Menconi and E. Bonmassar",
year = "1977",
doi = "10.1016/S0031-6989(77)80060-X",
language = "English",
volume = "9",
pages = "689--699",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press",
number = "8",

}

TY - JOUR

T1 - Immunostimulation before chemotherapy in cancer treatment

AU - Frati, L.

AU - Barzi, A.

AU - Caprino, M. C.

AU - Menconi, E.

AU - Bonmassar, E.

PY - 1977

Y1 - 1977

N2 - Synergism between chemotherapy and immune responses has been evidenced in animals and man. In addition, non-specific immunostimulation seems to increase the efficiency of anticancer chemotherapy. Up to now most of the clinical trials have been conducted applying immunoadjuvants after initial chemotherapeutic treatment. Since presensitized immunocompetent cells are more radio- and chemo-resistant than non-stimulated lymphocytes, a trial of immunostimulation before chemotherapy is based on rational experimental basis. Such program, activated in humans during 1976, is conducted according to the following general scheme:o1.Chemotherapy alone2.Chemotherapy followed by BCG and recycle3.Chemotherapy preceded and followed by BCG and recycle. Protocols for breast, lung, colorectal and ovarian cancer treatment are described.

AB - Synergism between chemotherapy and immune responses has been evidenced in animals and man. In addition, non-specific immunostimulation seems to increase the efficiency of anticancer chemotherapy. Up to now most of the clinical trials have been conducted applying immunoadjuvants after initial chemotherapeutic treatment. Since presensitized immunocompetent cells are more radio- and chemo-resistant than non-stimulated lymphocytes, a trial of immunostimulation before chemotherapy is based on rational experimental basis. Such program, activated in humans during 1976, is conducted according to the following general scheme:o1.Chemotherapy alone2.Chemotherapy followed by BCG and recycle3.Chemotherapy preceded and followed by BCG and recycle. Protocols for breast, lung, colorectal and ovarian cancer treatment are described.

UR - http://www.scopus.com/inward/record.url?scp=0017642124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017642124&partnerID=8YFLogxK

U2 - 10.1016/S0031-6989(77)80060-X

DO - 10.1016/S0031-6989(77)80060-X

M3 - Article

C2 - 563086

AN - SCOPUS:0017642124

VL - 9

SP - 689

EP - 699

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

IS - 8

ER -